NNC0480-0389 / Novo Nordisk |
NCT04878406: A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Japanese Men |
|
|
| Completed | 1 | 24 | Japan | NNC0480-0389, Placebo (NNC0480-0389), Semaglutide, Placebo (Semaglutide) | Novo Nordisk A/S | Healthy Volunteers Type 2 Diabetes | 07/21 | 07/21 | | |
NCT05046873: A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People |
|
|
| Completed | 1 | 16 | Europe | Co-formulation NNC0480 0389+Semaglutide A 10/1 mg/mL, semaglutide 1.34 mg/mL (placebo), Semaglutide 1.34 mg/mL, NNC0480-0389 A 10 mg/mL | Novo Nordisk A/S | Diabetes Mellitus, Type 2 | 01/22 | 01/22 | | |
NCT04259801: First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People With Diabetes |
|
|
| Completed | 1 | 152 | Europe | NNC0480-0389, Semaglutide, Placebo (NNC0480-0389), Placebo (semaglutide) | Novo Nordisk A/S | Healthy Volunteers, Overweight, Obesity, Diabetes Mellitus, Type 2 | 03/22 | 03/22 | | |
NCT05015894: A Research Study Looking Into Blood Levels of the Medicine NNC0480-0389 in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney Function |
|
|
| Completed | 1 | 42 | Europe | NNC0480-0389 | Novo Nordisk A/S | Diabetes Mellitus, Type 2 | 08/22 | 08/22 | | |
NCT05153564: A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After Menopause |
|
|
| Completed | 1 | 27 | Europe | Semaglutide 1.34 mg/mL, Semaglutide 3.0 mg/mL, NNC0480-0389 10 mg/mL, NNC0480-0389 30 mg/mL, Microgynon® | Novo Nordisk A/S | Diabetes Mellitus, Type 2 | 08/22 | 09/22 | | |
NCT05498610: A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Chinese Men |
|
|
| Completed | 1 | 24 | RoW | NNC0480 0389, Semaglutide | Novo Nordisk A/S | Diabetes Mellitus, Type 2 | 10/22 | 10/22 | | |